$CIHN The trial will focus on providing therapies
Post# of 249
Posted On: 06/03/2014 10:13:28 AM
$CIHN The trial will focus on providing therapies to limited option patients. Data collected will be compared against a control segment of standard, non-treated patients. Additionally, outcomes and safety data from Arm 2 patients will be compared against Arm 1 to establish differentials in therapy modalities.
(0)
(0)BioStem Technologies, Inc. (BSEM) Stock Research Links
Scroll down for more posts ▼